<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02178449</url>
  </required_header>
  <id_info>
    <org_study_id>DEXATrial1</org_study_id>
    <secondary_id>GS4-EK-2/304-2013</secondary_id>
    <nct_id>NCT02178449</nct_id>
  </id_info>
  <brief_title>Prolongation of Pain Free Time by the Use of Dexamethasone in Peripheral Nerve Blockade</brief_title>
  <official_title>The Effect of Dexamethasone Used Together With Low Volume Ropivacaine in a Single Shot Interscalene Block on the Pain Free Time Experienced by the Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Landesklinikum Sankt Polten</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Landesklinikum Sankt Polten</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main aim of the study is to investigate the proven effect of dexamethsone on the duration
      of the interscalene block. The investigators try to define optimal dose and volume for
      ropivacaine, when used together with dexamethsone. The current literature uses often very
      high volumes of ropivacain when used together with dexamethasone. The investigators try to
      research the effect of using dexamethsone together with low volume, high concentration
      ropivacaine for interscalene blockade. The investigators' hypothesis is that dexamethasone
      has an positive effect on the pain free after used together with ropivacaine at the scalene
      block.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain free time measured by the duration between block and the point at which the patient is asking for painkillers</measure>
    <time_frame>Patients will be followed during their stay at the hospital, which will be normally around 24 to 48 hours.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Rating Scale for Pain at Movement and Rest</measure>
    <time_frame>Measured 10 hours after the intervention</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>1 day, when the patient leaves the hospital</time_frame>
    <description>Measured by a validated questionary</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">109</enrollment>
  <condition>Interscalene Block</condition>
  <condition>Shoulder Arthroscopy</condition>
  <condition>Dexamethasone</condition>
  <condition>Low Volume Regional Anesthesia</condition>
  <arm_group>
    <arm_group_label>Verum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexamethasone and Ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ropivacaine and Saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone acetate</intervention_name>
    <arm_group_label>Verum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <arm_group_label>Verum</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  atroscopy of the shoulder

          -  repair of the RM

        Exclusion Criteria:

          -  patient under 18 years

          -  patient is fertile

          -  chronic opiat use more than 30mg oxycodone per day

          -  operations at the shoulder that involves the bone

          -  usage of cortisone for more than 2 weeks

          -  risk greater as asa III

          -  damage to nerves

          -  neuropathy at the target arm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Hörmann, MD</last_name>
    <role>Study Director</role>
    <affiliation>Landesklinikum Sankt Polten</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christoph Hörmann, MD</last_name>
    <phone>+ 43 2742 9004</phone>
    <email>office@stpoelten.lknoe.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Landesklinikum Sankt Pölten</name>
      <address>
        <city>Sankt Pölten</city>
        <state>Lower Austria</state>
        <zip>3100</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Hörmann, MD</last_name>
      <phone>+43 2742 9004</phone>
      <email>office@stpoelten.lknoe.at</email>
    </contact>
    <investigator>
      <last_name>Christoph Hörmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Landesklinikum Sankt Pölten</name>
      <address>
        <city>Sankt Pölten</city>
        <state>Lower Austria</state>
        <zip>3100</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Hörmann, MD</last_name>
      <phone>+43 2742 9004</phone>
      <email>office@stpoelten.lknoe.at</email>
    </contact>
    <investigator>
      <last_name>Christoph Hörmann</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2014</study_first_submitted>
  <study_first_submitted_qc>June 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2014</study_first_posted>
  <last_update_submitted>June 27, 2014</last_update_submitted>
  <last_update_submitted_qc>June 27, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 30, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>October 1, 2015</submitted>
    <returned>October 29, 2015</returned>
    <submitted>March 2, 2016</submitted>
    <returned>March 31, 2016</returned>
    <submitted>April 1, 2016</submitted>
    <returned>May 6, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

